Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7089273

CC(C)[O-].O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[Al+3]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
ACHE P22303 2/20 0.32
KCNH2 Q12809 6/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL1293248 0.91 GPR3 (0.39) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL184938 0.84 CA1 (0.44) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL893770 0.84 CA1 (0.44) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL1703694 0.81 CA1 (0.41) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL12274876 0.81 CA1 (0.41) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL28543595 0.81 CA1 (0.41) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL27638561 0.80 GPR3 (0.34) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL27713142 0.80 GPR3 (0.34) GPR3CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL7089272 0.80 ALDH1A1 (0.36) CA1CA2CA7CA13
Trifluoromethanesulfonic Acid SCHEMBL31676686 0.78 GPR3 (0.33) GPR3CA1CA2CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885CA1 479/4885CA2 1508/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885CA1 479/4885CA2 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.